Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy 2021-03-03 08:00
EZZ Life Science Holdings Limited to list on the ASX today following oversubscribed A$6m IPO 2021-03-03 07:52
VUNO presents its state-of-the-art AI medical imaging technology at ECR 2021 2021-03-02 23:00
Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand 2021-03-02 22:05
Sunquest Lauded by Frost & Sullivan for Driving Efficiency and Compliance with Its Differentiated Molecular Laboratory Information Management System 2021-03-02 22:00
Ambu Acclaimed by Frost & Sullivan for Its Groundbreaking Single-use Flexible Endoscopes 2021-03-02 21:00
Cloud-based Enterprise Imaging to Help Expedite Healthcare Providers' Journey of Enabling Better Care 2021-03-02 20:03
Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal 2021-03-02 20:00
Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area 2021-03-02 18:12
Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg) 2021-03-02 16:01
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug 2021-03-02 15:21
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody 2021-03-02 13:43
Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB 2021-03-02 07:00
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
New NCCN Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined Cancers 2021-03-01 21:35
China Biologic Announces Shareholders' Approval of Merger Agreement 2021-03-01 21:00
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants 2021-03-01 21:00
Frost & Sullivan Reveals Virtual Care's Enormous Potential in the United States 2021-03-01 20:02
Medilink Therapeutics Raises $50 Million in Series A Financing To Accelerate Next-Generation Conjugated Drugs Research & Development 2021-03-01 19:50
CARsgen Therapeutics Receives Orphan Medicinal Product Designation from the European Medicines Agency for CT041 CLDN18.2 CAR T Cells for the Treatment of Gastric Cancers 2021-03-01 19:00
1 650 651 652 653 654 1619